FDA lifts clinical hold following review of Company’s Complete Response submission.Company expects to restart U.S. enrollment in late 2025 or ...
Teeth naturally wear down over time, but scientists have found that they could signal certain cells to regrow bones, opening new avenues in stem cell research.
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
News Medical on MSN
N6-Methyladenosine: New Target for Acute Lung Injury
Acute lung injury (ALI) is a critical clinical condition characterized by diffuse inflammation of the lung parenchyma and intractable hypoxemia ...
The study showed that exercise combined with omega-3 significantly improves immune function and reduces the severity of ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...
Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...
Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...
Blocking caspase-9, an enzyme involved in cell death, may be a potential treatment target for pulmonary fibrosis, a ...
Objectives There is a lack of knowledge about whether occupational exposures increase the risk of emphysema, especially in ...
Introduction Although there are some drugs to control Parkinson’s disease (PD), they have several side effects and cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback